Simplex Trading’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,000
| Closed | -$4K | – | 10091 |
|
|
2023
Q2 | $4K | Sell |
3,000
-500
| -14% | -$715 | ﹤0.01% | 8131 |
|
|
2023
Q1 | $5K | Buy |
3,500
+1,200
| +52% | +$2.18K | ﹤0.01% | 8101 |
|
|
2022
Q4 | $3K | Sell |
2,300
-700
| -23% | -$2.04K | ﹤0.01% | 8456 |
|
|
2022
Q3 | $12K | Buy |
3,000
+1,400
| +88% | +$5.93K | ﹤0.01% | 8107 |
|
|
2022
Q2 | $6K | Sell |
1,600
-500
| -24% | -$1.42K | ﹤0.01% | 8766 |
|
|
2022
Q1 | $9K | Sell |
2,100
-5,700
| -73% | -$17.2K | ﹤0.01% | 9001 |
|
|
2021
Q4 | $28K | Sell |
7,800
-5,500
| -41% | -$29.3K | ﹤0.01% | 8015 |
|
|
2021
Q3 | $166K | Hold |
13,300
| – | – | ﹤0.01% | 5897 |
|
|
2021
Q2 | $150K | Buy |
13,300
+12,845
| +2,823% | +$129K | ﹤0.01% | 6135 |
|
|
2021
Q1 | $419K | Buy |
455
+188
| +70% | +$1.96K | ﹤0.01% | 3630 |
|
|
2020
Q4 | $185K | Sell |
267
-64
| -19% | -$334 | ﹤0.01% | 4723 |
|
|
2020
Q3 | $144K | Buy |
331
+316
| +2,107% | +$2.76K | ﹤0.01% | 4513 |
|
|
2020
Q2 | $13K | Buy |
15
+1
| +7% | +$15 | ﹤0.01% | 6517 |
|
|
2020
Q1 | $20K | Buy |
14
+11
| +367% | +$239 | ﹤0.01% | 5971 |
|
|
2019
Q4 | $3K | Sell |
3
-1
| -25% | -$17 | ﹤0.01% | 6915 |
|
|
2019
Q3 | $10K | Buy |
4
+1
| +33% | +$29 | ﹤0.01% | 6272 |
|
|
2019
Q2 | $6K | Buy |
3
+2
| +200% | +$77 | ﹤0.01% | 6393 |
|
|
2019
Q1 | $4K | Buy |
+1
| New | +$23 | ﹤0.01% | 6595 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$4K | – | 7976 |
|
|
2018
Q3 | $4K | Sell |
1
-3
| -75% | -$228 | ﹤0.01% | 6883 |
|
|
2018
Q2 | $31K | Hold |
4
| – | – | ﹤0.01% | 5520 |
|
|
2018
Q1 | $1K | Buy |
4
+3
| +300% | +$514 | ﹤0.01% | 5842 |
|
|
2017
Q4 | $1K | Buy |
+1
| New | +$94 | ﹤0.01% | 5680 |
|
|
2017
Q3 | – | Sell |
-2
| Closed | -$2K | – | 6809 |
|
|
2017
Q2 | $2K | Hold |
2
| – | – | ﹤0.01% | 5381 |
|
|
2017
Q1 | $2K | Sell |
2
-1
| -33% | -$143 | ﹤0.01% | 5381 |
|
|
2016
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 5556 |
|
|
2016
Q3 | $2K | Buy |
+3
| New | +$423 | ﹤0.01% | 5090 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$2K | – | 6289 |
|
|
2015
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 4765 |
|
|
2015
Q2 | $4K | Buy |
+1
| New | +$531 | ﹤0.01% | 3903 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$3K | – | 5730 |
|
|
2014
Q4 | $3K | Buy |
+1
| New | +$451 | ﹤0.01% | 3560 |
|
Simplex Trading's VIRX Position: Q2 2025 in Review
Simplex Trading sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2025, closing a stake of 400 shares.
Simplex Trading first reported a position in VIRX in Q3 2015 and held it in 23 quarters. The position peaked at $96K in Q1 2017. 0 funds tracked by Wall St. Rank hold VIRX as of Q2 2025.
- Simplex Trading reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 400 Viracta Therapeutics, Inc. Common Stock shares in Q2 2025.
- Simplex Trading first reported a position in Viracta Therapeutics, Inc. Common Stock in Q3 2015 and held it in 23 quarters.
- Simplex Trading's Viracta Therapeutics, Inc. Common Stock position peaked at $96K in Q1 2017.
- 0 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.